Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04246112 · ClinicalTrials.gov registry record · NA
A Handwriting Intervention Program for Children With Tic Disorders
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04246112 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 12 participants.
The verdict
NCT04246112, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effectiveness of a computerized handwriting training protocol (MovAlyzeR), through daily practice of handwriting on an electronic device to improve handwriting skills in children with tic disorders (TD).
Interventions
- OTHER Handwriting intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-01-12 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04246112
The ClinicalTrials.gov registry entry for NCT04246112 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Handwriting intervention is the first listed.
NCT04246112 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04246112 about?
NCT04246112 is a clinical study titled "A Handwriting Intervention Program for Children With Tic Disorders". The purpose of this study is to evaluate the effectiveness of a computerized handwriting training protocol (MovAlyzeR), through daily practice of handwriting on an electronic device to improve handwriting skills in children with tic disorders (TD).
What is the current status of trial NCT04246112?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2021-01-12. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT04246112?
The interventions under investigation include: Handwriting intervention (OTHER).
Who is sponsoring clinical trial NCT04246112?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.